Hermetica Superfood Encyclopedia
The Short Answer
Carpolobia lutea derives its primary bioactivity from saponins (21.02 mg/L in root extracts), which permeabilize cell membranes, stimulate luteinizing hormone release, and exert antioxidant and immunomodulatory effects. In rat models, ethanolic stem-bark extract demonstrated significant antidiarrheal activity at 43.3–173.2 mg/kg (p<0.05–0.001) and elevated testosterone levels over 60 days at doses of 47–141 mg/kg body weight, though no equivalent human clinical trial data currently exists.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordCarpolobia lutea benefits
Da marzaya — botanical close-up
Health Benefits
**Antidiarrheal Activity**
Ethanolic stem-bark extract inhibited castor oil-induced diarrhea in rats across doses of 43.3, 86.6, and 173.2 mg/kg (p<0.05–0.001), with the mechanism linked to adrenergic receptor modulation and nitric oxide pathway interactions confirmed via yohimbine and isosorbide dinitrate antagonism studies.
**Aphrodisiac and Libido Enhancement**
Saponins in the root stimulate pituitary release of luteinizing hormone, which in turn drives gonadal testosterone synthesis; this mechanism underpins widespread traditional use of the plant as a male sexual tonic across West African communities.
**Male Reproductive Support**
Rat studies administering 47 mg/kg and 141 mg/kg of extract for 60 days produced statistically significant increases in germinal epithelium diameter (p<0.05), suggesting a spermatogenic benefit, likely mediated by elevated endogenous testosterone and improved testicular microcirculation.
**Gastroprotection and Anti-Ulcerogenic Effects**
Traditional and experimental evidence supports the use of Carpolobia lutea extracts for gastric mucosal protection; tannins and saponins are considered the primary agents responsible through their astringent, membrane-stabilizing, and anti-inflammatory actions on the gastrointestinal epithelium.
**Antimicrobial Properties (including Gonorrhea)**
Extracts have demonstrated in vitro antimicrobial activity against pathogens including Neisseria gonorrhoeae, attributed to alkaloids (2.93 mg/L in root extract) and anthraquinones (5.11 mg/L) that disrupt bacterial membrane integrity and inhibit essential microbial enzymes.
**Antioxidant Defense**: Flavonoids (1
82 mg/L in root extract) and saponins contribute to free radical scavenging activity, reducing oxidative stress markers in experimental systems; this antioxidant capacity may underlie multiple secondary benefits including anti-inflammatory and hepatoprotective actions.
**Antinociceptive (Pain Relief) Effects**
Animal models have documented dose-dependent pain relief attributed to Carpolobia lutea extracts, with alkaloids and flavonoids implicated in central and peripheral pain pathway modulation, supporting its ethnomedicinal use for general pain management.
Origin & History
Natural habitat
Carpolobia lutea is a shrub native to the humid tropical forests and forest margins of West and Central Africa, with documented distribution across Nigeria, Ghana, Cameroon, and the Democratic Republic of Congo. It thrives in secondary forest understories and riverine zones where humidity is consistently high. The plant is not widely cultivated commercially; most material used in traditional medicine is wild-harvested, with the root bark and stem bark being the most prized plant parts.
“Carpolobia lutea has a deeply embedded history in the ethnomedicine of West and Central African communities, where the plant is known by various regional names including Da marzaya in northern Nigeria, reflecting its cultural reach across diverse linguistic groups. Traditional healers (herbalists) across Nigeria, Ghana, and Cameroon have long prescribed root and bark preparations to men experiencing sexual dysfunction, low libido, or infertility, positioning the plant as one of the region's premier androgenic botanicals. Beyond reproductive applications, the plant holds recognized status in community healthcare as a remedy for diarrhea, malaria, pain, and gastrointestinal ulcers, demonstrating broad therapeutic attribution typical of foundational West African medicinal flora. Documentation of its use predates modern scientific inquiry and has been preserved through oral tradition and ethnobotanical surveys conducted from the 1980s onward, which have provided the ethnopharmacological rationale driving current laboratory investigation.”Traditional Medicine
Scientific Research
The current body of evidence for Carpolobia lutea consists entirely of in vitro phytochemical analyses and animal (rodent) studies; no peer-reviewed human clinical trials with defined sample sizes, control groups, or measurable effect sizes have been published to date. Antidiarrheal efficacy has been established in Wistar rat models with statistically significant results (p<0.05–0.001) at three dose levels of ethanolic stem-bark extract, and reproductive studies in rats over 60 days have documented testosterone elevation and histomorphometric changes in testicular tissue at multiple dose levels (p<0.05). Antimicrobial activity, including against gonorrhea-causing organisms, has been demonstrated primarily in agar diffusion and broth dilution assays rather than in any controlled human infection studies. The absence of Phase I, II, or III human clinical trials represents a critical and acknowledged gap; extrapolation of animal dose-response data to human therapeutic recommendations is not scientifically valid without pharmacokinetic bridging studies.
Preparation & Dosage
Traditional preparation
**Ethanolic Stem-Bark Extract (Experimental)**
2 mg/kg for antidiarrheal effects and 47–141 mg/kg for reproductive effects; no validated human equivalent dose has been established
Used in animal studies at 43.3–173..
**Aqueous Decoction (Traditional)**
Bark or roots are boiled in water for 15–30 minutes in West African traditional practice; consumed as a tea for diarrhea, sexual vitality, and general wellness, though preparation concentrations are unstandardized.
**Root Bark Preparation**
02 mg/L vs
Root bark is considered more potent than stem bark due to higher saponin concentrations (21.. lower stem values); traditionally chewed or prepared as a cold-water infusion for aphrodisiac use.
**Standardization**
No commercial standardized extract or defined phytochemical specification (e.g., percentage saponins) currently exists; this represents a significant barrier to safe supplemental use.
**Timing**
Traditional use for aphrodisiac effects involves daily consumption over extended periods; experimental animal studies administered extracts daily for 60 days to observe reproductive outcomes.
**Human Dosing Guidance**
Human supplemental dosing cannot be responsibly recommended in the absence of Phase I pharmacokinetic data, bioavailability studies, or established safe upper intake levels.
Nutritional Profile
Carpolobia lutea is not consumed as a food ingredient and has no established macronutrient profile. Its pharmacological relevance derives from its phytochemical composition: root extracts contain saponins (21.02 mg/L), anthraquinones (5.11 mg/L), alkaloids (2.93 mg/L), flavonoids (1.82 mg/L), tannins (0.91 mg/L), and trace cardiac glycosides (0.09 mg/L). Stem-bark extracts are rich in potassium (1.00 ± 0.01 mg/g) and phosphorus (0.80 ± 0.030 mg/g) among cations, with significant phosphate anions (33.50 ± 7.09 mg/g) and sulfate (7.19 ± 3.29 mg/g). Leaf extracts contain free amino acids including proline, alanine, serine, valine, glycine, glutamate, and lysine. Bioavailability data for these compounds in humans is entirely absent from the published literature, and the pharmacokinetic behavior of the saponin fraction following oral ingestion has not been characterized.
How It Works
Mechanism of Action
The dominant bioactive class, saponins, acts by intercalating into phospholipid bilayers and permeabilizing cell membranes, which can disrupt microbial integrity and facilitate intracellular signaling in host tissues; simultaneously, saponins stimulate hypothalamic-pituitary axis activity, increasing luteinizing hormone (LH) secretion to upregulate gonadal testosterone biosynthesis. Anthraquinones and alkaloids contribute antimicrobial effects by inhibiting bacterial DNA gyrase and disrupting electron transport chains in pathogens. The antidiarrheal mechanism operates through activation of alpha-2 adrenergic receptors—reducing intestinal secretion and motility—and modulation of nitric oxide (NO) synthesis, as evidenced by attenuation of extract effects with the adrenergic blocker yohimbine and the NO donor isosorbide dinitrate. Tannins and flavonoids exert complementary antioxidant and anti-inflammatory actions by quenching reactive oxygen species, inhibiting cyclooxygenase (COX) enzyme activity, and stabilizing lysosomal membranes, collectively reducing prostaglandin-driven inflammation.
Clinical Evidence
No human clinical trials have been conducted or published for Carpolobia lutea as of the available literature, making formal clinical evidence summaries premature. Animal studies in rats provide proof-of-concept for antidiarrheal and androgenic effects, with significant outcomes at intraperitoneal and oral doses ranging from 43.3 to 173.2 mg/kg for gastrointestinal endpoints and 47 to 141 mg/kg for reproductive endpoints. An acute toxicity study determined an LD₅₀ of 866.025 mg/kg intraperitoneal in rats, classifying the extract as 'slightly toxic' at that threshold, with lethality observed at 1500 mg/kg i.p. Confidence in translating these animal findings to human clinical benefit is low; the evidence base currently supports hypothesis generation and justifies future Phase I safety and pharmacokinetic studies in humans rather than any therapeutic recommendations.
Safety & Interactions
The acute LD₅₀ of Carpolobia lutea ethanolic extract was determined to be 866.025 mg/kg intraperitoneal in rats, with mortality at 1500 mg/kg i.p., leading researchers to classify it as 'slightly toxic' by Hodge and Sterner scale criteria; however, intraperitoneal LD₅₀ values are not directly translatable to safe oral doses in humans. No systematic human adverse event data, drug interaction studies, or contraindication profiles have been established, representing a critical safety documentation gap that precludes confident use recommendations. Given the presence of cardiac glycosides—even at low concentrations (0.09 mg/L)—there is a theoretical risk of interaction with cardiac medications, digoxin, and antiarrhythmic drugs; saponins may also affect drug absorption by altering intestinal membrane permeability. Use during pregnancy and lactation is contraindicated based on precautionary principles, given complete absence of safety data in these populations and the plant's known hormonal activity (LH stimulation and testosterone elevation), which could adversely affect fetal or neonatal development.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Carpolobia lutea G. DonDa marzayaPoor man's candle (English vernacular)Ugwutseke (Igbo, Nigeria)Polygalaceae shrub
Frequently Asked Questions
What is Da marzaya used for in traditional medicine?
Da marzaya (Carpolobia lutea) is used across West Africa primarily as an aphrodisiac and male fertility enhancer, an antidiarrheal remedy, and a treatment for sexually transmitted infections including gonorrhea. Traditional healers also apply it to gastric ulcers, malaria, and general pain relief, making it one of the more broadly utilized medicinal shrubs in the region's ethnobotanical repertoire.
Does Carpolobia lutea actually increase testosterone?
Animal studies in rats demonstrated significant testosterone elevation after 60 days of daily extract administration at doses of 47, 94, and 141 mg/kg body weight, with concurrent increases in germinal epithelium diameter (p<0.05). The mechanism involves saponin-mediated stimulation of luteinizing hormone (LH) release from the pituitary; however, no human clinical trials have confirmed this effect in men, so direct translation to human testosterone levels remains unverified.
Is Carpolobia lutea safe to take as a supplement?
Safety data for human use of Carpolobia lutea is largely absent from the published scientific literature. The extract has an LD₅₀ of 866 mg/kg intraperitoneal in rats (classified 'slightly toxic'), and the presence of cardiac glycosides creates a theoretical risk of interaction with heart medications. Without human pharmacokinetic or toxicological studies, no safe supplemental dose can be responsibly defined, and use should be approached with caution pending further research.
How does Carpolobia lutea treat diarrhea?
Ethanolic stem-bark extract of Carpolobia lutea inhibited castor oil-induced diarrhea in rat models in a dose-dependent manner (43.3–173.2 mg/kg, p<0.05–0.001), with the mechanism involving modulation of alpha-2 adrenergic receptors that reduce intestinal secretion and motility. Nitric oxide pathway involvement was also demonstrated through pharmacological antagonism studies. These are preclinical findings only; no controlled human trials on its antidiarrheal efficacy have been conducted.
What are the main bioactive compounds in Carpolobia lutea root?
The root extract of Carpolobia lutea is dominated by saponins at 21.02 mg/L, which are considered the primary pharmacologically active compounds responsible for hormonal and antimicrobial effects. Other significant phytochemicals include alkaloids (2.93 mg/L), anthraquinones (5.11 mg/L), flavonoids (1.82 mg/L), tannins (0.91 mg/L), and trace cardiac glycosides (0.09 mg/L), collectively accounting for its diverse reported biological activities.
What is the difference between Carpolobia lutea root and stem-bark extracts?
Carpolobia lutea root and stem-bark contain different bioactive profiles suited to different traditional uses. The root is traditionally valued for saponin content supporting libido and reproductive health, while the stem-bark ethanolic extract demonstrated potent antidiarrheal effects in clinical studies, with efficacy confirmed across multiple dose levels (43.3–173.2 mg/kg). The stem-bark extract's mechanism involves adrenergic receptor modulation and nitric oxide pathway interactions, making it specifically effective for gastrointestinal applications.
Does Carpolobia lutea interact with blood pressure or cardiovascular medications?
Carpolobia lutea's antidiarrheal mechanism involves adrenergic receptor modulation, which theoretically could affect blood pressure regulation. Study antagonism experiments using yohimbine (an alpha-adrenergic antagonist) and isosorbide dinitrate (a nitric oxide donor) revealed the ingredient's interaction with these pathways, suggesting potential interactions with cardiovascular or blood pressure medications. Consultation with a healthcare provider is recommended before combining Carpolobia lutea with antihypertensive or cardiac medications.
What does scientific research reveal about the antidiarrheal strength of Carpolobia lutea compared to standard treatments?
Carpolobia lutea stem-bark ethanolic extract showed dose-dependent antidiarrheal activity in rat studies, with statistical significance achieved at all tested doses (p<0.05–0.001) using the castor oil-induced diarrhea model. The ingredient's mechanism—involving adrenergic receptor and nitric oxide pathway modulation—differs from conventional antidiarrheals, suggesting a distinct pharmacological approach. However, direct human clinical trials comparing Carpolobia lutea to standard antidiarrheal medications remain limited, so equivalency claims cannot yet be made.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w da-marzaya-carpolobia-lutea curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
